| Financial Year |
March 31 2023 |
| Monetary Funds |
15,962,319,468.54 |
| Held-for-trading Financial Assets |
1,384,877,215.29 |
| Notes Receivable |
103,561,103.78 |
| Accounts Receivable |
1,985,565,053.19 |
| Advances to Suppliers |
496,041,757.56 |
| Other Receivables |
136,234,900.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
12,340,000.00 |
| Inventories |
5,082,933,441.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
516,948,569.93 |
| Total Current Assets |
27,499,932,320.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,778,849,525.31 |
| Investment Properties |
222,260,183.18 |
| Fixed Assetes |
10,459,348,342.35 |
| Under-construction Projects |
9,568,775,541.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,533,203,767.47 |
| R&D expenses |
-- |
| Goodwill |
62,546,981.26 |
| Long-Term Deferred and Prepaid Expenses |
133,078,773.78 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
101,169,687.67 |
| Sub-Total of Non-Current Assets |
30,964,335,080.60 |
| Total Assets |
58,464,267,400.94 |
| Short-Term Loans |
3,137,699,231.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
848,491,448.10 |
| Accounts Payable |
4,552,929,444.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
125,547,942.89 |
| Taxes Payable |
125,471,820.74 |
| Interest Payable |
-- |
| Dividend Payable |
16,309,450.24 |
| Other payables |
2,615,360,007.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
504,796,366.97 |
| Other Current Liabilities |
163,189,461.11 |
| Sub-Total of Current Liabilities |
22,789,457,742.94 |
| Long-term Loans |
5,837,407,364.98 |
| Bonds Payable |
2,414,861,574.93 |
| Long-Term Accounts Payable |
146,745,172.53 |
| Special Payable |
-- |
| Estimatied Liabilities |
13,691,700.00 |
| Deferred Income Tax Liabilities |
76,476,873.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,499,173,038.39 |
| Total Liabilities |
32,288,630,781.33 |
| Paid-In Capital(Or Share Stock) |
2,131,449,598.00 |
| Capital Surplus |
9,101,955,731.00 |
| Surplus Reserve |
739,507,943.80 |
| LESS:Treasury Stock |
102,771,473.00 |
| Undistributed Profits |
10,062,619,934.03 |
| Minority Stockholder's Interest |
4,393,840,898.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,781,795,721.54 |
| Owner's Equity（Stockholder's Equity） |
26,175,636,619.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
58,464,267,400.94 |
